ֲý

Zarela Lourdes Molle-Rios, MD

GI Attending

ֲý Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803

Biography

I am a Pediatric Gastroenterologist working at ֲý Children's Hospital for the last 24 years. The clinical experience in treating a variety of gastrointestinal conditions has instilled in me the importance of combining clinical work with a research agenda. I have strong interest in clinical and translational research in pediatric inflammatory disease. I am also interested in pediatric obesity translational research.

Fellowship

  • Pediatric Gastroenterology - ֲý/Alfred I. duPont Hospital for Children, 2003
  • Pediatric Gastroenterology - SUNY Downstate Medical Center, 1998

Residency

  • Pediatrics - Cayetano Heredia University Hospital, 1990

Internship Residency

  • Pediatrics - Children's Medical Center Brooklyn, 1995

Medical/Dental School

  • MD - Cayetano Heredia University, 1986

Board Certifications

  • American Board of Pediatrics/General Pediatrics
  • American Board of Pediatrics/Gastroenterology

  • Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease (PRODUCE): A Series of N-of-1 Diet Trials. ; The American journal of gastroenterology; (2022).

  • The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity; Pediatric Gastroenterology, Hepatology & Nutrition; (2021).

  • Branched chain amino acid-inflammation relationship in youth with obesity: A randomized controlled intervention study.; The Journal of clinical endocrinology and metabolism; (2021).

  • Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease.; American journal of human genetics; (2021).

  • Oncostatin-M Does Not Predict Treatment Response in Inflammatory Bowel Disease in a Pediatric Cohort.; Journal of pediatric gastroenterology and nutrition; (2021).

  • Report on the Short Endoscopic Exocrine Pancreatic Function Test in Children and Young Adults.; Pancreas; (2020).

  • Salivary pepsin A detection related to gastro‐oesophageal reflux episodes in children undergoing impedance probe monitoring; Acta Paediatrica; (2020).

  • Underutilization of Bowel Ultrasound in North America in Children with Inflammatory Bowel Disease; Digestive Diseases; (2019).

  • P014 Case Series of Small Bowel Crohn's Disease Diagnosed in 10 Pediatric Patients by Video Capsule Endoscopy; American Journal of Gastroenterology; (2019).

  • Mo1797 – Impact of Premedication and Other Variables on the Formation of Antibodies to Infliximab in Pediatric Inflammatory Bowel Disease; Gastroenterology; (2019).

  • Use of Electronic Health Record Tools to Facilitate and Audit Infliximab Prescribing; The Journal of Pediatric Pharmacology and Therapeutics; (2018).

  • Creating the Subspecialty Pediatrics Investigator Network.; The Journal of pediatrics; (2018).

  • Spontaneous Gastric Perforation in Two Adolescents; American Journal of Case Reports; (2016).

  • Safety of Secretin Administration in Children; Pancreas; (2016).

  • P-168 YI Inflammatory Colitis in an Infant; Inflammatory Bowel Diseases; (2013).

  • T1164 Mucocutaneous Granulomatous Disease in a Patient On Infliximab Therapy; Gastroenterology; (2009).

  • Clinical quiz.; Journal of pediatric gastroenterology and nutrition; (2006).

  • Hepatitis C infection in children and adolescents with end-stage renal disease; Pediatric Nephrology; (2002).

  • Endoscopic features of smooth muscle tumors in children with AIDS; Gastrointestinal Endoscopy; (2000).

  • []; Digestive Diseases and Sciences; (1999).

  • Neonatal hypoperistalsis associated with perinatal zidovudine administration.; Journal of perinatology : official journal of the California Perinatal Association; (1998).